Sio Capital Management, LLC

Holdings History for Aligos Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (ALGS)

Symbol: ALGS on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 335,937 shares
Security Ownership %: 5.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Sio Capital Management, LLC ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

11 Feb 2026 - Sio Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 335,937 shares of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS). This represents 5.5% ownership of the company. In their previous filing dated 13 Aug 2025, Sio Capital Management, LLC had reported owning 355,937 shares, indicating a decrease of +5.6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Sio Capital Management, LLC	5.5%	-0.6%	$3,104,058	335,937	-20,000	-5.6%	$9.24	13G/A	31 Dec 2025	11 Feb 2026, 16:32
Sio Capital Management, LLC	5.5%		$2,566,306	355,937			$7.21	13G	30 Jun 2025	13 Aug 2025, 14:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.52%	0%	$3,130,933	335,937	0		$9.32	Q4 2025
30 Sep 2025	0.83%	0%	$3,292,183	335,937	0		$9.80	Q3 2025
30 Jun 2025	0.97%	+0.45%	$2,422,106	335,937	+155,217	+86%	$7.21	Q2 2025
31 Mar 2025	0.45%	+0.45%	$1,490,940	180,720	+180,720	NEW	$8.25	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.